News

Vaccitech Appoints Two Independent Board Directors

Oxford, UK - Vaccitech Ltd., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the appointment of two new...

Oxford University breakthrough on global COVID-19 vaccine

Oxford, UK - Vaccitech’s scientific founders at University of Oxford announce positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil. Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is...

Vaccitech expands management team with hires including CMO and CFO

Oxford, UK – Vaccitech Ltd, a clinical-stage biopharmaceutical company developing T cell vaccines and immunotherapies designed to treat and prevent infectious disease and cancer, today announces the appointment of three new senior leaders across its clinical,...